Organizations like yours are familiar to us. We are chemists, engineers, molecular biologists, researchers, and scientists who combine our technical understanding with legal, regulatory, and compliance excellence to provide you with well-informed counsel – from your patent portfolio development, protection, and monetization strategies to market entry and exit strategies.
Whether you are an inventor, start-up, venture capitalist, investor, Fortune 50 or Fortune 500 company, or research institution we help people like you on all aspects of pharmaceuticals, biotechnology and medical devices. We understand that regulatory and compliance will dominate your thinking – and can help you meet your requirements on every issue from M&A to tax, HR and real estate.
We know that often in this industry, time is of the essence, and we are proud that we continually demonstrate that we can work at speed without compromising on efficiency. This is demonstrated by our looking at patents for potential vaccines and detection methods, as well as dealing with urgent approval for medical devices and personal protective equipment.
Whatever your background, we can help you commercialize your inventions, protect key intellectual property and structure your business and partnerships to best enable you to bring the next generation of medicines, products and services to market.
Some of our recent work includes:
- representing an US pharmaceutical company in the reorganization of its Austrian distribution organization
- advising a market-leading Austrian home nursing services provider on the organization and the standard agreements for its 24-hour care
- advising in unfair trade litigation regarding advertisement for drugs and medical devices
- advising life sciences companies on all issues of public procurement of medicinal products by hospitals and governmental agencies
- advising a pharmaceutical wholesaler on issues of the verification of the authenticity of medicinal products and related issues of data protection
Latest Insights
- legal updatesThe EDPB’s new scientific research guidelines: a welcome route map, but no shortcut for “research” by assertion
- legal updatesHong Kong: Open consultation on listing reforms
- legal updatesEU Legislation Roundup: February 2026
- legal updatesHow statutory warranty laws differ across jurisdictions
Latest News
- firm newsEversheds Sutherland Advises The Centurion Foundation on Completed Acquisition of Roger Williams Medical Center and Fatima Hospital
- client newsEversheds Sutherland advises on £5.2bn disposal of Barchester Healthcare
- client newsEversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
- firm newsEversheds Sutherland continues IP and Life Sciences practice expansion with European lateral partner hire
legal updates
April 28, 2026
The EDPB’s new scientific research guidelines: a welcome route map, but no ...
legal updates
April 14, 2026
Hong Kong: Open consultation on listing reforms
legal updates
March 05, 2026
EU Legislation Roundup: February 2026
legal updates
March 02, 2026
How statutory warranty laws differ across jurisdictions
firm news
March 20, 2026
Eversheds Sutherland Advises The Centurion Foundation on Completed Acquisit...
client news
November 06, 2025
Eversheds Sutherland advises on £5.2bn disposal of Barchester Healthcare
client news
September 06, 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of C...
firm news
November 03, 2022
Eversheds Sutherland continues IP and Life Sciences practice expansion with...